Screening efficiency of the Mood and Feelings Questionnaire (MFQ) and Short Mood and Feelings Questionnaire (SMFQ) in Swedish help seeking outpatients

Jarbin, Håkan; Ivarsson, Tord; Andersson, Markus; Skarphéðinsson, Guðmundur

doi:10.1371/journal.pone.0230623

Cited by 33 publications

(36 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A score of 12 or higher may indicate the presence of clinically relevant depressive symptoms in the respondent 15 . Suggested cut-offs on the SMFQ self-report have been divergent with cut-offs ranging from 4–5 in studies with just fair AUC and younger subjects to a high of 10–12 in studies with good AUCs and older subjects 16 .…”

Section: Methodsmentioning

confidence: 99%

Depressive symptoms in response to COVID-19 and lockdown: a cross-sectional study on the Italian population

Delmastro¹,

Zamariola

2020

Sci Rep

View full text Add to dashboard Cite

The COVID-19 pandemic and the lockdown orders adopted to prevent the spread of the disease had a huge impact on a personal, social, and economic level for the world population. In Europe, Italy was one of the frontrunner countries dealing with an emergency that significantly affected people’s lives. Previous research on the psychological impact of the pandemic revealed an increase in anxiety, depression, and feelings of distress; however, these studies were conducted on non-representative samples of the population reached through social media channels, a method that is likely to lead to many forms of statistical and methodological bias. For the first time to our knowledge, we assessed the psychological impact of COVID-19 on 6700 Italian individuals, representative of the Italian population in terms of age, gender, and geographical areas revealing higher scores of depressive symptoms in females, younger adults, people reporting professional uncertainty and lower socio-economic status. A positive correlation was also found for individuals living alone, those who could not leave home for going to work, and people with a case of COVID-19 in the family, whereas the region of residence was not a significant predictor of depressive symptoms. These findings underline the importance of considering the psychological effects of COVID-19 and providing support to individuals seeking mental health care.

show abstract

Section: Methodsmentioning

confidence: 99%

Depressive symptoms in response to COVID-19 and lockdown: a cross-sectional study on the Italian population

Delmastro¹,

Zamariola

2020

Sci Rep

View full text Add to dashboard Cite

show abstract

“…Good to excellent internal consistency was found in the current sample ( α = 0.91). To divide the sample into depressed and non-depressed, the SMFQ scores were dichotomized to above clinical cut-off ( n = 163) and below clinical cut-off ( n = 150), applying a cutoff score of ≥12 for girls and ≥6 for boys, according to criteria suggested by Jarbin et al (2020) .…”

Section: Methodsmentioning

confidence: 99%

“…Depression below clinical cut-off a (n = 150) Jarbin et al (2020). β, standardized beta; GAD, generalized anxiety disorder; OCD, obsessive compulsive disorder; SAD, separation anxiety disorder; SCAS, spence children's anxiety scale; SMFQ, short mood and feelings questionnaire; SoAD, social anxiety disorder; *p < 0.05, **p < 0.01, ***p < 0.001.…”

Section: Full Sample (N = 313)mentioning

confidence: 99%

“…Relative risk (RR) of insomnia in adolescents with anxiety by total anxiety symptoms (SCAS), and anxiety subtypes, adjusted for age, sex, and depressive symptoms (SMFQ), including sub-analyses on adolescents below clinical cut-off for depression, estimated from log-binomial regressions. Clinical cut-off for depressive symptoms ≥6 for boys and ≥12 for girls according toJarbin et al (2020). GAD, generalized anxiety disorder; OCD, obsessive compulsive disorder; SAD, separation anxiety disorder; SCAS, spence children's anxiety scale; SMFQ, short mood and feelings questionnaire; SoAD, social anxiety disorder.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Sleep Duration and Insomnia in Adolescents Seeking Treatment for Anxiety in Primary Health Care

et al. 2021

View full text Add to dashboard Cite

There is limited knowledge about sleep in adolescents with elevated levels of anxiety treated within primary health care settings, potentially resulting in sleep problems not being sufficiently addressed by primary health care workers. In the current study self-reported anxiety, insomnia, sleep onset latency, sleep duration, and depressive symptoms were assessed in 313 adolescents (12–16 years; mean age 14.0, SD = 0.84, 84.0% girls) referred to treatment for anxiety within primary health care. Results showed that 38.1% of the adolescents met criteria for insomnia, 34.8% reported short sleep duration (<7 h), and 83.1% reported long sleep onset latency (≥30 min). Total anxiety symptoms were related to all sleep variables after controlling for age and sex. Furthermore, all anxiety symptom sub-types were associated with insomnia and sleep onset latency, whereas most anxiety subtypes were associated with sleep duration. Adolescents’ depressive symptoms accounted for most of the anxiety-sleep associations, emphasizing the importance of depressive symptoms for sleep. However, anxiety was associated with insomnia and sleep onset latency also among youth with low levels of depressive symptoms. The findings suggests that primary health care workers should assess sleep duration, sleep onset latency, and insomnia in help-seeking adolescents with anxiety.

show abstract

“…This is supported by findings from studies in help-seeking adolescents. Jarbin et al (2020) suggested a lower cut-point for boys (≥6) compared to girls (≥12) and Thabrew et al (2018) suggested a cut-point of ≥12 for boys and ≥13 for girls. It is not clear to what extent age or puberty are responsible for the sex differences in cut-points.…”

Section: Discussionmentioning

confidence: 99%

Validation of the short Mood and Feelings Questionnaire in young adulthood

Eyre

Jones

Agha

et al. 2021

Preprint

View full text Add to dashboard Cite

BackgroundDepression often onsets in adolescence and is associated with recurrence in adulthood. There is a need to identify and monitor depression symptoms across adolescence and into young adulthood. The short Mood and Feelings Questionnaire (sMFQ) is commonly used to measure depression symptoms in adolescence but has yet to be validated in young adulthood. This study aimed to (1) examine whether the sMFQ is a valid assessment of depression in young adults, and (2) identify cut-points that best capture a DSM-5 diagnosis of depression at age 25.MethodsThe sample included young people who took part in the Avon Longitudinal Study of Parents and Children (ALSPAC) at age 25 (n=4098). Receiver Operating Characteristic analyses were used to examine how well the self-rated sMFQ discriminates between cases and non-cases of DSM-5 Major Depressive Disorder (MDD) classified using the self-rated Development and Well Being Assessment. Sensitivity and specificity values were used to identify cut-points on the sMFQ.ResultsThe sMFQ had high accuracy for discriminating MDD cases from non-cases at age 25. The commonly used cut-point in adolescence (≥12) performed well at this age, best balancing sensitivity and specificity. However, a lower cut-point (≥10) may be appropriate in some contexts, e.g. for screening, when sensitivity is favoured over specificity.LimitationsALSPAC is a longitudinal population cohort that suffers from non-random attrition.ConclusionsThe sMFQ is a valid measure of depression in young adults in the general population. It can be used to screen for and monitor depression across adolescence and early adulthood.

show abstract

Screening efficiency of the Mood and Feelings Questionnaire (MFQ) and Short Mood and Feelings Questionnaire (SMFQ) in Swedish help seeking outpatients

Cited by 33 publications

References 35 publications

Depressive symptoms in response to COVID-19 and lockdown: a cross-sectional study on the Italian population

Depressive symptoms in response to COVID-19 and lockdown: a cross-sectional study on the Italian population

Sleep Duration and Insomnia in Adolescents Seeking Treatment for Anxiety in Primary Health Care

Validation of the short Mood and Feelings Questionnaire in young adulthood

Contact Info

Product

Resources

About